ReviewInternational journal of molecular sciences2022

Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity.

Nischal Koirala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.